2009, 2019

Elizabeth Holmes & Theranos: From Innovator to Fraudster

By |September 20th, 2019|Categories: Due Diligence|

When it comes to technological breakthroughs, the focus remains on paradigm shifts: everyone wants to take part in the next big thing, the next breakthrough that will revolutionize the way that the world works. As the self-styled Steve Jobs of the healthcare industry, Elizabeth Holmes promised investors this degree of innovation with her startup, Theranos. Years later, with Holmes’ criminal trial date announced for the summer of 2020, her Silicon Valley debacle creeps back into the national spotlight, positing her as a fraud rather than an innovator.

609, 2019

Globalizing the GDPR: Can Anti-Corruption Practices Withstand the Evolving State of Personal Data Protection?

By |September 6th, 2019|Categories: Cyber|

May 2018 marked the onset of a series of data protection changes that appeared would impact just one part of the world. At this time, the European Commission enforced the General Data Protection Regulation (GDPR), thereby intensifying personal data protection standards for EU-participatory companies. Any corporation operating or conducting business in the EU became subject to the updated criteria, whether an entity directly registered in the region or a foreign business targeting EU consumers.

3008, 2019

Hindsight is 20/20: How-to Avoid Investing in a Soon-to-Fail Startup

By |August 30th, 2019|Categories: Due Diligence|

It’s no secret that many of the tech industry’s current giants had humble beginnings as small startups in dire need of financial support from investors. Just the opposite, in fact: once a firm is more established, an underdog story of early self-sufficiency can make for a great marketing campaign about passion, ambition, and leadership coming together to create a service or product - with the help of a little seldom-mentioned outside funding.